nbUVB phototherapy

DEVICE2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), University of Colorado, Denver

Conditions

Vitiligo

Phase 2

Evaluation of AMG 714 for Vitiligo

CompletedNCT04338581

National Institute of Allergy and Infectious Diseases (NIAID)Vitiligo

Start: 2020-12-11End: 2025-04-02Updated: 2025-12-09

Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo

CompletedNCT05298033

University of Colorado, DenverVitiligo

Start: 2022-09-07End: 2024-04-30Updated: 2024-06-12